These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 11521211

  • 1. Fetal nucleated red blood cell counts in peripheral blood of mothers bearing Down syndrome fetus.
    Parano E, Falcidia E, Grillo A, Takabayashi H, Trifiletti RR, Pavone P.
    Neuropediatrics; 2001 Jun; 32(3):147-9. PubMed ID: 11521211
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification of nucleated red blood cells in maternal circulation: a second step in screening for fetal aneuploidies and pregnancy complications.
    Mavrou A, Kouvidi E, Antsaklis A, Souka A, Kitsiou Tzeli S, Kolialexi A.
    Prenat Diagn; 2007 Feb; 27(2):150-3. PubMed ID: 17186566
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA, Peterson CJ, French CA, Saller DN, Arvan DA.
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE.
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prenatal diagnosis].
    Miny P, Tercanli S, Gänshirt D, Holzgreve W.
    Ther Umsch; 1995 Dec; 52(12):792-800. PubMed ID: 8539649
    [Abstract] [Full Text] [Related]

  • 14. Prenatal detection of trisomy 21 on nucleated red blood cells enriched from maternal circulation by using fluorescence in situ hybridization.
    Hromadnikova I, Hridelova D, Houbova B, Vavrinec J, Kofer J, Krofta L, Calda P.
    Prenat Diagn; 2002 Sep; 22(9):836-9. PubMed ID: 12224084
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
    Bahado-Singh RO, Oz U, Shahabi S, Mahoney MJ, Baumgarten A, Cole LA.
    Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Cost-benefit analysis of prenatal screening for trisomy 21 through analysis of HCG in maternal blood].
    Seror V, Moatti JP, Muller F, Le Galès C, Boué A.
    Rev Epidemiol Sante Publique; 1993 Nov; 41(1):3-15. PubMed ID: 8465062
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modifying risk for aneuploidy with second-trimester ultrasound after a positive serum screen.
    Timms D, Campbell WA.
    Clin Lab Med; 2010 Sep; 30(3):677-92. PubMed ID: 20638581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.